-
NMPA, Ministry of Public Security, National Health Commission issued the Announcement on the Inclusion of Oxycodone-Containing Compound Preparations in the Management of Psychotropic Substances
2019-08-06
NMPA,the Ministry of Public Security, and the National Health Commission decided to include oxycodone containing compound preparations in the management of psychotropic substances.
-
NMPA Issued the Notice on Enabling the New Version of the Drug Production License and other Certificates
2019-08-07
To standardize the formats and renewal of the drug administrative licenses, on August 7, 2019, NMPA issued the Notice on Enabling the New Version of the Drug Production License and other Certificates,and notified the relevant matters as follows.
-
NMPA Issued the Administrative Measures for Drug Quality Sampling Inspection
2019-08-19
NMPA issued the Administrative Measures for Drug Quality Sampling Inspection,effective as of the date of promulgation.
-
NMPA Issued Three Informationization Standards such as the Basic Technical Requirements for Drug Traceability System
2019-08-27
NMPA has issued three informationization standards such as the basic technical requirements for drug traceability system.
-
NMPA Issued the Guiding Principles for Capacity Building of Drug Inspection and Testing Institutions
2019-08-30
NMPA has organized the formulation of and released on August 30,2019 the Guiding Principles for Capacity Building of Drug Inspection and Testing Institutions.
-
Newly Revised Drug Administration Law Adopted After Deliberation —To Comprehensively Implement the Four Strictest Requirements and Effectively Protect Drug Safety for the Public
2019-08-26
The remarkable results of pharmaceutical reforms and effective practices were transformed into laws to beef up rule of law for public health.
